The updated definition of hypertension by the American College of Cardiology (ACC) and the American Heart Association (AHA) is an important paradigm shift and has lead to extensive discussion. We aimed to examine the association between the updated blood pressure (BP) categories and the risk of cardiovascular diseases (CVDs) with potential modifications from other cardiovascular health metrics (CVHMs).
This prospective study included 91,204 participants ≥40 years recruited from 20 community sites across mainland China. Participants were followed up during 2010-2016 for CVD events including nonfatal myocardial infarction, stroke, heart failure, and cardiovascular death. BP categories were defined according to the 2017 ACC/AHA guideline and CVHMs included smoking, physical activity, diet, body-mass index, total cholesterol, and fasting glucose.
Overall, 1,985 major CVD events occurred during a mean follow-up of 3.7 years. Having more ideal CVHMs significantly reduced the risk of CVD events in both stage 1 and stage 2 hypertension. Compared with participants without hypertension, participants having ≥4 ideal CVHMs were no longer associated with an increased CVD risk in stage 1 hypertension (HR=1·04; 95% CI=0·83-1·31), but less so in stage 2 hypertension (HR=1·90, 95% CI=1·70-2·13). Such pattern of association was more evident in participants aged <60 years ( for interaction <0·05).
Stage 1 hypertension defined by the ACC/AHA identifies individuals at increased CVD risk, which can be attenuated by achieving more preferable cardiovascular health, especially in adults aged <60 years.
© 2021 Published by Elsevier Ltd.
About The Expert
Shujing Wu
Yu Xu
Ruizhi Zheng
Jieli Lu
Mian Li
Li Chen
Yanan Huo
Min Xu
Tiange Wang
Zhiyun Zhao
Shuangyuan Wang
Hong Lin
Meng Dai
Di Zhang
Jingya Niu
Guijun Qin
Li Yan
Qin Wan
Lulu Chen
Lixin Shi
Ruying Hu
Xulei Tang
Qing Su
Xuefeng Yu
Yingfen Qin
Gang Chen
Zhengnan Gao
Guixia Wang
Feixia Shen
Zuojie Luo
Yuhong Chen
Yinfei Zhang
Chao Liu
Youmin Wang
Shengli Wu
Tao Yang
Qiang Li
Yiming Mu
Jiajun Zhao
Yufang Bi
Weiqing Wang
Guang Ning
References
PubMed